News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Avisi was founded in 2017 by Penn students Rui Jing J., the company's CEO, and Brandon Kao and Adarsh Battu, who were studying business and engineering.
Nicola Mason, BVetMed, PhD, of Penn Vet was featured on CBS' 60 Minutes, where she spoke about her research on immunotherapy treatment for cancer in dogs.
Penn spinout Avisi Technologies raised $4.06 million in a seed round led by Accanto Partners.
In the article, Swartley discusses some key highlights from FY22, including the major impact Penn technologies have made on patients.
Henderson, Penn alumna and Philly native, will spearhead the implementation of Pennovation’s long-range strategic plan, including development of the site, marketing, communications and leasing.
A Penn Dental Medicine study found that cavity-causing microbes have the ability to form superorgranisms that can sprout “limbs” that propel them to“leap” to quickly spread on the tooth surfaces.
The lightweight, non-invasive wristband device can detect the stroke symptoms in as little as 15 minutes.
CBS This Morning recently featured a story about Emily Whitehead, the first pediatric patient to receive Penn-invented CAR T cell therapy to fight cancer.
The PCI Ventures at Pennovation Works Showcase took place in October 2022, in celebration of Pennovation Works' 6th Anniversary and PCI Ventures' 12 years of service to the Penn community.
PCI Ventures, a division of PCI specifically focused on creating early-stage businesses founded on Penn technology, recently held a showcase at Pennovation Works.